Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
50439.62%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 17Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information
Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYELL IMMUNOPHARMA INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYEL - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 53K | $ 26.73M | 50439.62% |
| 3/31/2025 | $ 58K | $ 30.01M | 51746.55% |
| 12/31/2024 | $ 61K | $ 33.14M | 54334.43% |
| 9/30/2024 | $ 63K | $ 33.52M | 53212.7% |
| 6/30/2024 | $ 54K | $ 36.42M | 67440.74% |
| 3/31/2024 | $ 68K | $ 42.36M | 62289.71% |
| 12/31/2023 | $ 130K | $ 47.08M | 36218.46% |
| 9/30/2023 | $ 48.5M | $ 56.98M | 117.49% |
| 6/30/2023 | $ 48.48M | $ 65.59M | 135.29% |
| 3/31/2023 | $ 84.19M | $ 73.78M | 87.63% |
Key Performance Insights, Last 5 Years
- LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) SB Comp % stands at 428.84%.
- Over the past 5 years, LYELL IMMUNOPHARMA INC's average SB Comp % has been 23647.07%.
- The median SB Comp % for LYELL IMMUNOPHARMA INC during this period was 700.2%
- LYELL IMMUNOPHARMA INC reached its highest SB Comp % over the past 5 years at 67440.74%.
- The lowest SB Comp % recorded by LYELL IMMUNOPHARMA INC in the same timeframe 87.63%
LYELL IMMUNOPHARMA INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for LYELL IMMUNOPHARMA INC is calculated as follows: SB Comp. [ $ 33.26M ] / Revenues [ $ 7.76M ]
(=) SB Comp % [ 428.84% ] LYEL - Stock Based Compensation Margin, Last 5 years
87.63%
Minimum
Mar 31, 2023
67440.74%
Maximum
Jun 30, 2024
23647.07%
Average
700.2%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.99K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |